MC
PGEN icon

Moors & Cabot’s Precigen PGEN Stock Holding History

Moors & Cabot’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-16,280
Closed -$543K – 540
2016
Q1 		$543K Sell
16,280
-1,413
-8% -$44.5K 0.1% 241
2015
Q4 		$534K Sell
17,693
-1,160
-6% -$39.1K 0.1% 241
2015
Q3 		$597K Buy
18,853
+3,113
+20% +$152K 0.11% 231
2015
Q2 		$758K Buy
15,740
+3,550
+29% +$150K 0.12% 201
2015
Q1 		$534K Buy
+12,190
New +$438K 0.09% 258

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Moors & Cabot's PGEN Position: Q2 2016 in Review

Moors & Cabot sold out of Precigen (PGEN) in Q2 2016, closing a stake of 16,280 shares — an estimated $543K sold.

Moors & Cabot first reported a position in PGEN in Q1 2015 and held it in 5 quarters. The position peaked at $758K in Q2 2015. 169 funds tracked by Wall St. Rank hold PGEN as of Q2 2016.

  • Moors & Cabot reported no remaining Precigen position as of Q2 2016 after selling out during the quarter.
  • Moors & Cabot sold 16,280 Precigen shares in Q2 2016, an estimated $543K.
  • Moors & Cabot first reported a position in Precigen in Q1 2015 and held it in 5 quarters.
  • Moors & Cabot's Precigen position peaked at $758K in Q2 2015.
  • 169 funds tracked by Wall St. Rank held Precigen as of Q2 2016.

Based on Moors & Cabot's 13F filing for Q2 2016, filed 8 Aug 2016.